- Home
- OIS vs ZBIO Comparison
OIS vs ZBIO Comparison
Compare OIS & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- ZBIO
- Stock Information
- Founded
- OIS 1995
- ZBIO 2019
- Country
- OIS United States
- ZBIO United States
- Employees
- OIS N/A
- ZBIO N/A
- Industry
- OIS Metal Fabrications
- ZBIO
- Sector
- OIS Industrials
- ZBIO
- Exchange
- OIS Nasdaq
- ZBIO NYSE
- Market Cap
- OIS 361.0M
- ZBIO 339.3M
- IPO Year
- OIS 2001
- ZBIO 2024
- Fundamental
- Price
- OIS $5.73
- ZBIO $8.40
- Analyst Decision
- OIS Buy
- ZBIO Strong Buy
- Analyst Count
- OIS 3
- ZBIO 5
- Target Price
- OIS $6.50
- ZBIO $31.75
- AVG Volume (30 Days)
- OIS 485.7K
- ZBIO 371.9K
- Earning Date
- OIS 02-18-2025
- ZBIO 02-16-2025
- Dividend Yield
- OIS N/A
- ZBIO N/A
- EPS Growth
- OIS N/A
- ZBIO N/A
- EPS
- OIS N/A
- ZBIO N/A
- Revenue
- OIS $736,259,000.00
- ZBIO N/A
- Revenue This Year
- OIS N/A
- ZBIO N/A
- Revenue Next Year
- OIS N/A
- ZBIO N/A
- P/E Ratio
- OIS N/A
- ZBIO N/A
- Revenue Growth
- OIS N/A
- ZBIO N/A
- 52 Week Low
- OIS $3.91
- ZBIO $7.50
- 52 Week High
- OIS $6.57
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- OIS 69.48
- ZBIO N/A
- Support Level
- OIS $5.06
- ZBIO N/A
- Resistance Level
- OIS $5.86
- ZBIO N/A
- Average True Range (ATR)
- OIS 0.21
- ZBIO 0.00
- MACD
- OIS 0.08
- ZBIO 0.00
- Stochastic Oscillator
- OIS 87.95
- ZBIO 0.00
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore/Manufactured Products, Well Site Services and Downhole Technologies. It erns maximum revenue from Offshore/Manufactured Products.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.